The rare Disease Foundation has posted a great article on this: Click here to view their article
Information on the Webinar hosted by the CFA
Posted from https://www.businesswire.com
Information on the Webinar hosted by the CFA
Are You Interested in Sharing Your Experience with Fabry Disease? If so, Fulcrum Research Group, an independent, third-party market research firm, is seeking Fabry patients or their caregivers for a market research study. Specifically, the research will aim to gain a better understanding of individual patients’ experiences and opinions about: Their journey from initial symptoms […]
Information on the Webinar hosted by Taimi Lynch
Information on the Webinar hosted by Ryan Deveau
Hello Nova Scotia CFA members, A Patient Empowerment Meeting is coming your way! Put October 14th in your calendar and fill out the registration form to join us for an empowering day! Below is the information and also please click here to register!
Please keep reading for details! Registration: Click here
Full Press release link Idorsia Pharmaceuticals (www.idorsia.com), a Swiss biotech company, is developing lucerastat, a new oral therapy for patients with Fabry Disease. The Phase 3 clinical study MODIFY has just enrolled its first patients and will investigate the use of lucerastat monotherapy for the treatment of adult patients with Fabry disease, irrespective of their […]